Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amnon Amit

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Journal of Gynecology Obstetrics and Human Reproduction|August 30, 2022
Prediction of endometrial cancer recurrence by using a novel machine learning algorithm: An Israeli gynecologic oncology group studyOhad Houri, Yotam Gil, Ofer Gemer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 2, 2021
Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group studyOri Tal, Ram Eitan, Ofer Gemer, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 20, 2021
Minimally invasive approach in endometrial cancer with lower uterine segment involvement in stage ≥ II: A retrospective studyTamar Perri, Gabriel Levin, Limor Helpman, et al.
Surgical Oncology|September 6, 2020
Is the extent of pelvic lymphadenectomy in the staging of endometrial cancer associated with the yield of metastatic nodes? An Israeli Gynecologic Oncology Group studyMisgav Rottenstreich, Ofer Gemer, Limor Helpman, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 27, 2019
An Israeli Gynecologic Oncology Group study of statin use and endometrial cancer prognosisYakir Segev, Ofer Gemer, Limor Helpman, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 6, 2019
The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group studyAhmet Namazov, Ofer Gemer, Limor Helpman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 19, 2020
Increased ultrasonographic endometrial thickness is associated with poor survival in patients with endometrial cancer: An Israel gynecologic oncology group studyAhmet Namazov, Ofer Gemer, Nasreen Hag-Yahia, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 22, 2020
Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort studyNasreen Hag-Yahia, Ofer Gemer, Ram Eitan, et al.
American Journal of Obstetrics and Gynecology|May 25, 2018
Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group studyOfer Gemer, Yakir Segev, Limor Helpman, et al.
Gynecologic Oncology|December 22, 2007
Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)Hadassah Goldberg, Robert C Miller, Roxolyana Abdah-Bortnyak, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Journal of Gynecology Obstetrics and Human Reproduction|August 30, 2022
Prediction of endometrial cancer recurrence by using a novel machine learning algorithm: An Israeli gynecologic oncology group studyOhad Houri, Yotam Gil, Ofer Gemer, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 2, 2021
Prognostic significance of pretreatment thrombocytosis in endometrial cancer: an Israeli Gynecologic Oncology Group studyOri Tal, Ram Eitan, Ofer Gemer, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 20, 2021
Minimally invasive approach in endometrial cancer with lower uterine segment involvement in stage ≥ II: A retrospective studyTamar Perri, Gabriel Levin, Limor Helpman, et al.
Surgical Oncology|September 6, 2020
Is the extent of pelvic lymphadenectomy in the staging of endometrial cancer associated with the yield of metastatic nodes? An Israeli Gynecologic Oncology Group studyMisgav Rottenstreich, Ofer Gemer, Limor Helpman, et al.
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|September 27, 2019
An Israeli Gynecologic Oncology Group study of statin use and endometrial cancer prognosisYakir Segev, Ofer Gemer, Limor Helpman, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|November 6, 2019
The oncological safety of hysteroscopy in the diagnosis of early-stage endometrial cancer: An Israel gynecologic oncology group studyAhmet Namazov, Ofer Gemer, Limor Helpman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|October 19, 2020
Increased ultrasonographic endometrial thickness is associated with poor survival in patients with endometrial cancer: An Israel gynecologic oncology group studyAhmet Namazov, Ofer Gemer, Nasreen Hag-Yahia, et al.
Acta Obstetricia Et Gynecologica Scandinavica|October 22, 2020
Age is an independent predictor of outcome in endometrial cancer patients: An Israeli Gynecology Oncology Group cohort studyNasreen Hag-Yahia, Ofer Gemer, Ram Eitan, et al.
American Journal of Obstetrics and Gynecology|May 25, 2018
Is there a survival advantage in diagnosing endometrial cancer in asymptomatic postmenopausal patients? An Israeli Gynecology Oncology Group studyOfer Gemer, Yakir Segev, Limor Helpman, et al.
Gynecologic Oncology|December 22, 2007
Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN)Hadassah Goldberg, Robert C Miller, Roxolyana Abdah-Bortnyak, et al.
Pageof 7